dc.contributor.author |
Allott, Kelly |
|
dc.contributor.author |
Fisher, Caroline A |
|
dc.contributor.author |
Amminger, Gunther Paul |
|
dc.contributor.author |
Goodall, Joanne |
|
dc.contributor.author |
Hetrick, Sarah |
|
dc.coverage.spatial |
United States |
|
dc.date.accessioned |
2024-01-10T00:50:50Z |
|
dc.date.available |
2024-01-10T00:50:50Z |
|
dc.date.issued |
2016-10 |
|
dc.identifier.citation |
(2016). Brain and Behavior, 6(10), e00527-. |
|
dc.identifier.issn |
2162-3279 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/67152 |
|
dc.description.abstract |
Background:
Major depressive disorder (MDD) affects a quarter of adolescents and young adults and is associated with the greatest global burden of disease in this population. There is a growing literature, mostly in adults, showing that significant neurocognitive impairments are common in MDD. It remains unclear whether these impairments are pre-existing trait markers of MDD, state-related impairments that fluctuate with depressive symptoms, or ‘scar’ impairments that worsen with illness progression. The aim of this study is to provide a conceptual framework for understanding MDD and neurocognitive impairment in adolescence and young adulthood (ages 12–25 years).
Method:
Examination of the evidence for neurocognitive deficits as trait, state, and scar features of MDD according to different study designs (family studies, premorbid studies, current depression, remitted depression, and longitudinal studies with repeated assessment) was conducted.
Results:
The few premorbid and family studies conducted in youth provide equivocal evidence for neurocognitive impairments as trait markers of MDD. The presence of state-based neurocognitive impairment remains unclear as evidence comes mostly from cross-sectional studies. There are a limited, but growing number of longitudinal studies with repeated neurocognitive assessment in youth. Studies that examined neurocognition prior to the onset of MDD and with long-term follow-up provide tentative evidence for neurocognitive scarring.
Conclusion:
Neurocognitive impairment is a feature of MDD in adolescents and young adults. To better understand the nature, timing, and pattern of impairment, longitudinal studies that examine neurocognition before and after the development of full-threshold MDD, including following recurrence are needed. This knowledge will have important implications for mechanisms, prevention, and treatment of MDD in youth. |
|
dc.format.medium |
Electronic-eCollection |
|
dc.language |
eng |
|
dc.publisher |
Wiley |
|
dc.relation.ispartofseries |
Brain and behavior |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.rights.uri |
https://creativecommons.org/licenses/by/4.0/ |
|
dc.subject |
Humans |
|
dc.subject |
Depressive Disorder, Major |
|
dc.subject |
Adolescent |
|
dc.subject |
Adult |
|
dc.subject |
Child |
|
dc.subject |
Young Adult |
|
dc.subject |
Cognitive Dysfunction |
|
dc.subject |
adolescence |
|
dc.subject |
cognition |
|
dc.subject |
deficits |
|
dc.subject |
early intervention |
|
dc.subject |
major depressive disorder |
|
dc.subject |
neuropsychological |
|
dc.subject |
young adulthood |
|
dc.subject |
youth |
|
dc.subject |
32 Biomedical and Clinical Sciences |
|
dc.subject |
3202 Clinical Sciences |
|
dc.subject |
52 Psychology |
|
dc.subject |
Depression |
|
dc.subject |
Pediatric |
|
dc.subject |
Brain Disorders |
|
dc.subject |
Behavioral and Social Science |
|
dc.subject |
Neurosciences |
|
dc.subject |
Mental Health |
|
dc.subject |
Clinical Research |
|
dc.subject |
Serious Mental Illness |
|
dc.subject |
2.1 Biological and endogenous factors |
|
dc.subject |
2 Aetiology |
|
dc.subject |
3 Good Health and Well Being |
|
dc.subject |
Science & Technology |
|
dc.subject |
Life Sciences & Biomedicine |
|
dc.subject |
Behavioral Sciences |
|
dc.subject |
Neurosciences & Neurology |
|
dc.subject |
COGNITIVE DEFICITS |
|
dc.subject |
NEUROPSYCHOLOGICAL DEFICITS |
|
dc.subject |
SCHIZOPHRENIFORM DISORDER |
|
dc.subject |
ADOLESCENT DEPRESSION |
|
dc.subject |
TREATMENT REMISSION |
|
dc.subject |
EXECUTIVE FUNCTION |
|
dc.subject |
EARLY-CHILDHOOD |
|
dc.subject |
MENTAL-HEALTH |
|
dc.subject |
RISK-FACTORS |
|
dc.subject |
IQ SCORE |
|
dc.subject |
1103 Clinical Sciences |
|
dc.subject |
1117 Public Health and Health Services |
|
dc.subject |
Clinical |
|
dc.subject |
Clinical Medicine and Science |
|
dc.subject |
1109 Neurosciences |
|
dc.subject |
1701 Psychology |
|
dc.subject |
1702 Cognitive Sciences |
|
dc.subject |
3209 Neurosciences |
|
dc.subject |
5202 Biological psychology |
|
dc.title |
Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar? |
|
dc.type |
Journal Article |
|
dc.identifier.doi |
10.1002/brb3.527 |
|
pubs.issue |
10 |
|
pubs.begin-page |
e00527 |
|
pubs.volume |
6 |
|
dc.date.updated |
2023-12-28T20:58:49Z |
|
dc.rights.holder |
Copyright: The authors |
en |
dc.identifier.pmid |
27781141 (pubmed) |
|
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/27781141 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
Research Support, Non-U.S. Gov't |
|
pubs.subtype |
review-article |
|
pubs.subtype |
Review |
|
pubs.subtype |
Journal Article |
|
pubs.elements-id |
650330 |
|
pubs.org-id |
Medical and Health Sciences |
|
pubs.org-id |
School of Medicine |
|
pubs.org-id |
Psychological Medicine Dept |
|
dc.identifier.eissn |
2162-3279 |
|
dc.identifier.pii |
BRB3527 |
|
pubs.number |
ARTN e00527 |
|
pubs.record-created-at-source-date |
2023-12-29 |
|
pubs.online-publication-date |
2016-07-21 |
|